On 6 May 2025, the United Kingdom (UK) and Indian Governments agreed a new ‘landmark’ free trade agreement (“FTA”) to increase long-term bilateral trade by £25.5 billion each year and drive economic growth in both countries. The UK Government believes the FTA will result in a £4.8 billion increase in UK GDP and a £2.2…

The United Kingdom (UK) and the United States (US) have concluded a trade deal covering a range of products and promoting market access for goods.

In response to the recent additional tariffs adopted by the US administration, both countries agreed to the following:

• US import duties on UK-origin cars will be reduced from 27.5% to

…

The European Commission has unveiled a proposed response to the US tariffs on cars and automotive parts, as well as the so-called reciprocal tariffs. These countermeasures from the European Union (EU) will be adopted if the ongoing negotiations with the US administration fail. As mentioned in our last blog, the EU decided to pause…

In briefThe US Department of Commerce (“Commerce“) has initiated a Section 232 national security investigation into the imports of pharmaceuticals and pharmaceutical ingredients. This investigation aims to determine whether these imports threaten US national security. The scope of the investigation includes finished drug products, medical countermeasures, critical inputs such as active pharmaceutical ingredients (APIs), key…

Since April 24, 2024, the Ministry of Economy, Trade and Industry (METI) and the Ministry of Finance (MOF) had been conducting an anti-dumping investigation into graphite electrodes imported from China. As a result of the investigation, on 28 February 2025, METI and MOF issued a provisional determination that presumes the fact of dumping and the…

Following our previous post here, we provide an update on the current developments in this area.

On April 2, 2025, the US administration announced reciprocal tariffs on all imports into the United States (see here). As it has been widely reported, pharmaceutical products were exempted from these tariffs whereas medical devices were not.…

To date, Canada has implemented three rounds of retaliatory tariffs at a rate of 25% against certain US origin goods, with a fourth round of retaliatory tariffs pending after a public consultation period closed on April 2, 2025 (“Retaliatory Tariffs“). Canada has also announced several remission order processes which provide relief from the retaliatory tariffs.…